Skip to content
healthcare.dev

ZITUVIMET

NDC 70771-1859, Sitagliptin and Metformin Hydrochloride, tablet, film coated, from Zydus Lifesciences Limited.

Product NDC
70771-1859
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216743
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1859 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN50 mg/1
  • METFORMIN HYDROCHLORIDE500 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
70771-1859-67077118590660 TABLET, FILM COATED in 1 BOTTLE (70771-1859-6)
70771-1859-870771185908180 TABLET, FILM COATED in 1 BOTTLE (70771-1859-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0098dec4-f0e5-45d5-8aa4-5d0faf9ab142

Use it

Look up 70771-1859 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1859 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1859. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.